Keywords: cutaneous metastasis; distant metastasis; head and neck cancer; PD1-inhibitor; tonsillar carcinoma; CM; cutaneous metastases; DM; distant metastasis; HPV; human papillomavirus; SCC; squamous cell carcinoma; SCCHN; squamous cell carcinoma of head and neck;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: BCM; body cell mass; BIA; bioelectrical impedance analysis; BIS; bioelectrical impedance spectroscopy; C; capacitance; CLI; capillary leak index; ECV; extracellular fluid volume; FFM; fat free mass; FFMI; fat free mass index; FM; fat mass; FMI; fat mass i
Keywords: SCCHN; squamous cell carcinoma of the head and neck; SEER; Surveillance, Epidemiology, and End Results; HPV; human papillomavirus; LA; locoregionally advanced; Gy; gray; RTOG; Intergroup Radiation Therapy Oncology Group; GORTEC; Groupe d'Oncologie Radioth
Keywords: SCCHN; Individualised quality of life
Keywords: SCCHN; Immune system; Immunotherapy; Monoclonal antibodies; Clinical trials; Treatment combination;
Keywords: ADH; adipic acid dihydrazide; AUNPs; gold nanoparticles; BA; butyric acid; CDDP; cisplatin; CHI; chitosane; CNTs; carbon nanotubes; CPT; camptothecin; CSCs; cancer stem cells; DiPhPE; diphytanoyl-sn-glycero-3-glycerophosphatidyl ethanolamine; DL; drug loa
MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7
Keywords: SCCHN; Squamous cell carcinoma of head and neck; IGF-1R; insulin like growth factor 1 receptor; CCR7; C-C chemokine receptor type 7; cDNA; DNA complementary to RNA; UTR; untranslated region(s); TCGA; The Cancer Genome Atlas database; RT-PCR; Real-time pol
Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview
Keywords: Antibody-drug conjugates; Monoclonal antibodies; Anticancer; Drug resistance; Solid tumors; Hematological tumors; ADC; Antibody-Drug Conjugate; ALCL; Anaplastic Large Cell Lymphoma; ALL; Acute Lymphoblastic Leukemia; AML; Acute Myeloid Leukemia; BCMA; B C
Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data
Keywords: SCCHN; squamous cell carcinoma of the head and neck; c-MET; mesenchymal-epithelial transition factor; HGF; hepatocyte growth factor; PRISMA; Preferred Reporting Items for Systematic Reviews and Meta-Analyses; TNM; Tumour Node Metastasis; HPV; human papill
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial
Keywords: Cetuximab; IMCL-9815; Mucositis; Dysphagia; p16; HPV; SCCHN;
Targeting HER (ERBB) signaling in head and neck cancer: An essential update
Keywords: EGFR; HER; ERBB; SCCHN; Targeted therapy
Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway
Keywords: AREs; Antioxidant response elements; CI; Combination index; DRI; Dose reduction index; EGFR; Epidermal growth factor receptor; EMT; Epithelial-to-mesenchymal transition; GSK3β; Glycogen synthase kinase 3β; HDACi; Histone deacetylase inhibitor; HK1; Hexo
YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer
Keywords: Head and neck cancer; SCCHN; YAP1; Predictive marker; Treatment response; Gene copy number; Drug resistance
Differences in p63 expression in SCCHN tumours of different sub-sites within the oral cavity
Keywords: p63; SCCHN; Sub-site; Oral cavity; Tongue; Gingiva;
Role of OGG1 Ser326Cys polymorphism and 8-oxoguanine DNA damage in risk assessment of squamous cell carcinoma of head and neck in north Indian population
Keywords: SCCHN; OGG1 polymorphism; 8-OHdG; Genetic susceptibility; Life style factors;
Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study
Keywords: Gefitinib; Cisplatin; Radiotherapy; SCCHN; Randomized-phase II;
Hyaluronic acid–paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism
Keywords: SCCHN; HA–paclitaxel; CD44; Orthotopic
Targeting EGFR resistance networks in head and neck cancer
Keywords: EGFR; Epidermal growth factor receptor; Head and neck cancer; Signaling; Resistance pathways; SCCHN
CD4+ T helper responses in squamous cell carcinoma of the head and neck
Keywords: SCCHN; squamous cell carcinoma of the head and neck; MLTC; mixed lymphocyte-tumor cell cultures; wt; wild type; PBMCs; peripheral blood mononuclear cells; CTLs; cytotoxic T lymphocytes; PBLs; peripheral blood lymphocytes; TILs; tumor-infiltrating lymphocy
p63 contributes to cell invasion and migration in squamous cell carcinoma of the head and neck
Keywords: p63; Invasion; Migration; SCCHN
Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulation
Keywords: Docetaxel; Chemotherapy; G0 cells; SCCHN;
Expression of p53 isoforms in squamous cell carcinoma of the head and neck
Keywords: p53; p53β; p63; Isoforms; SCCHN
Cetuximab combined with radiotherapy: An alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?
Keywords: Chemoradiotherapy; Cetuximab; Erbitux; Locally advanced; Radiotherapy; SCCHN
A Retrospective Analysis of the Outcome of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Refractory to a Platinum-based Chemotherapy
Keywords: Patient outcome; SCCHN; second-line therapy;
Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: A randomised phase II study
Keywords: Docetaxel; Cisplatin; 5-Fluororacil; 5-FU; Neoadjuvant; SCCHN; Head and neck;
The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms
Keywords: HPV; SCCHN; ATM methylation; p53 Mutation;